Skip to main content
Home Research

Have Questions?

Please contact us or subscribe for more opportunities

Stay in Touch with Us

See what’s new.

https://otc.duke.edu/wp-content/uploads/2023/08/North-Carolina-Biotechnology-Center-NCBC.png

NCBiotech Awards $2.75 Million in Grants, Loans in Latest Quarter

Two Duke start-ups received loans & four Duke projects received Translational Research Grants. Recipients hail from across the university!

Read More

https://otc.duke.edu/wp-content/uploads/2023/08/zhou_pei_HERO2.jpg

Synthetic Antibiotic Could Be Effective Against Drug-Resistant Superbugs

Decades of work by a series of Duke investigators yields new drug, patents and a startup company Valanbio Therapeutics

Read More

https://otc.duke.edu/wp-content/uploads/2023/08/Benner-Study-01@0.25x.png

Newly Identified Lipid in Breast Milk Might Reduce Cerebral Palsy in Infants

Tellus Therapeutics, a neonatal white matter injury therapeutics start-up, was co-founded by Dr. Eric Brenner (Pediatrics, SOM)

Read More

https://otc.duke.edu/wp-content/uploads/2023/05/jungsang-kim-in-lab-photo.jpeg

First-time faculty gift to Duke Science and Technology to support university’s translation and commercialization efforts

$1M gift from IonQ co-founder Professor Jungsang Kim (ECE, Pratt) and Soyeon Nam helps OTC accelerate commercialization of Duke inventions

Read More

https://otc.duke.edu/wp-content/uploads/2023/05/tune-tx-nph-announcement-featured-image.png

Tune Therapeutics Unveils Breakthrough Data Showing Stable and Durable Epigenetic Regulation in Non-Human Primates

Tune Therapeutics is a Duke University start-up developing epigenetic editing spun out of the lab of co-founder Professor Charles Gersbach (BME, Pratt).

Read More

https://otc.duke.edu/wp-content/uploads/2023/04/IPDay2023_poster_landscape_template_editable_text_1920x1080.jpg

Duke University celebrates World Intellectual Property Day 2023

Duke University is ranked 18th in the Top 100 Worldwide Universities Granted Utility Patents by the National Academy of Inventors.

Read More

https://otc.duke.edu/wp-content/uploads/2023/03/evecxia-logo.png

Evecxia Therapeutics Reports Favorable Data From a Phase 1 Single Ascending Dose Safety/Tolerability/PK/PD Trial of EVX-301

Evecxia Therapeutics is a Duke University start-up, founded by inventors Drs. Jacob Jacobsen and Marc Caron (Cell Biology, SOM) around their serotonin synthesis amplification therapeutic technology for mental health applications.

Read More

https://otc.duke.edu/wp-content/uploads/2023/03/Isolere-acquisition-story-cover.jpeg

Isolere Bio: Inside the journey of a Duke biotech start-up

From an invention in 1999, to start-up creation in 2017, to acquisition in 2023, learn of the twists and turns of Duke start-up Isolere Bio from its co-founders.

Read More

https://otc.duke.edu/wp-content/uploads/2023/03/Watch-Basics-of-Copyright-Data-and-Software-Intellectual-Property-recording-now-available-Large.jpeg

Watch: Basics of Copyright, Data, and Software Intellectual Property – recording now available

It has been said that content is king. Watch Duke's Daniel Dardani give an overview of copyright law with considerations of its history and relevance to IP.

Read More

1 2 3 9